2. 1. Mitsdoerffer M, Kuchroo V, Korn T. Immunology of neuromyelitis optica: a T cell–B cell collaboration. Ann N Y Acad Sci; 2013.1283(1):57-66.
3. 2. Chiu C, Xian W, Moss A. Flying in silence: Echolocating bats cease vocalizing to avoid sonar jamming. 2008;105(35): 13116-21.
4. 3. Melamed E, Levy M, Waters PJ, Sato DK, Bennett JL, Jhon GR, et al. Neurol Neuroimmunol Neuroinflamm; 2015.2(4):e134.
5. 4. Weinshenker BG, Wingerchuk DM, Pittok SJ, Lucchinetti CF, Lennon VA. NMO-IgG: a specific biomarker for neuromyelitis optica. Dis Markers; 2006.22(4):197-206.
6. 5. Jarius S, Wildemann B. The history of neuromyelitis optica. J Neuroinflammation; 2013.10(1):8.
7. 6. Aboul-Enein F, Rauschka H, Kornek B, Stadelmann C, Stefferl A, Bruck W, et al. Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases. J Neuropathol Experim Neurol; 2003.62(1):25-33.
8. 7. Kalluri SR, Illes Z, Srivastava R, Cree B, Menge T, Bennett JL, et al, editprs. Quantification and functional characterization of antibodies to native aquaporin 4 in neuromyelitis optica. Arch Neurol; 2010;67(10):1201-1208.
9. 8. Moore F Human herpes virus 6 and multiple sclerosis, Wolfson C. Acta Neurol Scand; 2002.106(2):63-83.
10. 9. Koga M, Takahashi T, Kawai M, Fujihara K, Kanda T. A serological analysis of viral and bacterial infections associated with neuromyelitis optica. J Neurol Sci; 2011.300(1):19-22.
11. 10. Mori M, Hosoya M, Hiwasa T, Hayakawa S, Uzawa A, Kuwabara S. Detection of mumps virus RNA in cerebrospinal fluid of patients with neuromyelitis optica. Neurol Sci; 2011.32(5):795-799.
12. 11. Zamvil SS, Slavin AJ. Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder? Neurol Neuroimmunol Neuroinflamm; 2015.2:e62.
13. 12. Hayakawa S, Mori M, Okuta A, Kamegawa A, Fujiyoshi Y, Yoshiyama Y, et al. Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay. J Neuroimmunol; 2008.196(1):181-187.
14. 13. Bansal R, Kalita J, Msra U, Kishore J. Myelitis: a rare presentation of mumps. Pediatr Neurosurg; 1998.28(4):204-206.
15. 14. Kashipazha D, Mohammadianinejad SE, Majdinasab N, Azizi M, Jafari M. A descriptive study prevalence, clinical features and other findings of neuromyelitis optica and neuromyelitis optica spectrum disorder in Khuzestan Province, Iran. Iran J Neuro; 2015.14:204.
16. 15. Etemadifar M, Dashti M, Vosoughi R, Abtahi SH, Ramagopalan SV, Nasr Z. An epidemiological study of neuromyelitis optica in Isfahan. Mult Scler; 2014.20:1920-22.
17. 16. Sahraian M, Moinfar Z, Khorramnia S, Mohammad Ebrahim M. Relapsing neuromyelitis optica: demographic and clinical features in Iranian patients. Eur J Neurol; 2010.17:79-49.
18. 17. Mealy MA, Wingerchuk DM, Greenberg BM, Levy M. Epidemiology of neuromyelitis optica in the United States: a multicenter analysis. Arch Neurol; 2012.69:1176-80.
19. 18. Sofroniew MV, Vinters HV. Astrocytes: biology and pathology. Acta Neuropathol; 2010.19:7-35.